Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Multiple drugs

Various toxicities: 9 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is: Drug interaction
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Gonzalez-Garcia R, et al. Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavir. Clinical Microbiology and Infection 29: 655e1-655e4, No. 5, 2023. Available from: URL: http://doi.org/10.1016/j.cmi.2023.01.002 Gonzalez-Garcia R, et al. Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavir. Clinical Microbiology and Infection 29: 655e1-655e4, No. 5, 2023. Available from: URL: http://​doi.​org/​10.​1016/​j.​cmi.​2023.​01.​002
Metadaten
Titel
Multiple drugs
Various toxicities: 9 case reports
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41981-6

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Pembrolizumab

Case report

Tacrolimus

Case report

Multiple drugs

Case report

Multiple drugs